Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
LytaJect IV
Medication labelWhy this: Advisory · dailymed-animal
LytaJect IV is indicated for replacement of acute extracellular fluid volume losses in surgery, trauma, burns or shock. JytaJect IV can be used as an adjunct to restore a decrease in circulatory volume in patients with moderate blood loss. lytaJect IV is not intended to supplant transfusion of whole blood or packed red cells in the presence of uncontrolled hemorrhage or severe reductions of red cell volume.
- generic_name
- multiple electrolyte injection type 1
- product_names
- Multiple Electrolyte Injection Type 1
- ndc
- 65207-827, 65207-827-80, 65207-827-61
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en